Other terms
- Postprandial Distress Syndrome (PDS)
- Pre-treatment Genomic-Based Cancer Screening
- Precision GI Medicine
- Precision Medicine
- Precision Oncology
- Presbyopia
- PDUFA
- Proteomics
- Protocol
- Protocol Amendments
- Protocol Deviations
- Prurigo Nodularis
Postmenopausal Osteoporosis
What is Postmenopausal Osteoporosis? Postmenopausal osteoporosis is age-related loss of bone tissue, causing bones to become brittle in postmenopausal women. The hormonal changes, specifically the decrease in estrogen after menopause, increase the rate of bone loss significantly. Osteoporosis is a common and often silent condition, affecting 1 in 10 women over the age of 60, and increasing the risk of fracture by 50%. Fractures in the elderly decrease the quality of life, increase risk of more fractures, and increase mortality.
Risk factors for Postmenopausal Osteoporosis
- Advanced age
- Family history of fractures
- Low body weight
- Caucasian or Asian ethnicity
- Vitamin D deficiency
- Low calcium diet
- Lack of exercise
- Cigarette smoking
- Excessive use of alcohol
- Use of glucocorticoids
- History of rheumatoid arthritis
Source: Endocrine Society. (2022, March 31). Osteoporosis. Retrieved June 2, 2022, from https://www.endocrine.org/patient-engagement/endocrine-library/osteoporosis
